Shares surged 6.2% to $67.63 as investors cheered Rocket Lab's announcement that it has fully financed its blockbuster acquisition of satellite operator Iridium Communications — removing the single biggest uncertainty hanging over the stock since the deal was unveiled in June.
Nearly $2 Billion in New Stock Clears the Cash Hurdle. Rocket Lab raised $1.944 billion through an at-the-market equity offering, issuing 29.3 million shares . Combined with available liquidity, the raise fully funds the cash consideration for the pending $8 billion Iridium acquisition, expected to close in mid-2027 . The market read this as execution, not desperation: the stock had already climbed steadily from $61.96 a week ago, and today's pop confirmed that clearing the financing bar matters more to investors right now than the share-count math.
Killing the Bridge Loan Cuts a Major Risk. Rocket Lab cancelled a $3.6 billion senior secured bridge facility it had arranged in June . Bridge loans are short-term, expensive stopgaps — replacing one with cheaper, permanent financing is significant. Iridium simultaneously amended its existing $1.775 billion term loan to permit the change of control, backed by Rocket Lab's parent guarantee . That means the combined company will lean on Iridium's own cash flow to service its debt rather than piling costly new borrowing on Rocket Lab's still-unprofitable balance sheet.
Iridium's Cash Flow Is the Prize — and the Justification. Iridium projects pro forma free cash flow of roughly $318 million in 2026 and expects $1.5–$1.8 billion cumulative free cash flow through the rest of the decade . The deal gives Rocket Lab recurring satellite-communications revenue, sticky defense and government customers, and the ability to compete as a network operator — not just a rocket builder. For a company posting $769 million in trailing revenue and still losing money, absorbing Iridium's profit stream would reshape the financial profile entirely.
Dilution Is Real, and It Isn't Over. Outstanding shares ballooned to 598 million by June 30 from 543.6 million at year-end 2025 — before the latest 29.3 million-share sale. That puts the post-offering count near ~630 million, a roughly 16% increase in under a year. Analysts' median price target sits at $120, suggesting the Street sees the combined entity as worth far more — but shareholders are betting that Iridium's cash generation will outgrow the ownership they gave up to get it. The deal still faces regulatory approval and an Iridium shareholder vote, leaving execution risk firmly on the table through mid-2027.